Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Feldman

Showing results (201-210 of 1,291) with videos related to

Pageof 130
Sort By:
Journal of the American Academy of Dermatology|February 18, 2010
Where did current academic dermatologists train?Ali Alikhan, Dina Farshidi, Steven R Feldman
Dermatology and Therapy|July 15, 2018
Effect of Prior Biologic Use on Cost-Effectiveness of Brodalumab vs. Ustekinumab for Treatment of Moderate-to-Severe Psoriasis in the United StatesSteven R Feldman, Shipra Rastogi, Jay Lin
Southern Medical Journal|May 13, 2009
Management of psoriasisAida J Al-Kudwah, Steven R Feldman
Journal of Drugs in Dermatology : JDD|June 16, 2006
Clobetasol propionate for psoriasis: are ointments really more potent?Lindsey Warino, Rajesh Balkrishnan, Steven R Feldman
Southern Medical Journal|January 5, 2017
Advances in PsoriasisJaclyn Smith, Abigail Cline, Steven R Feldman
JMIR Dermatology|August 26, 2023
Refusal of Retreatment With Topical 5-Fluorouracil Among Patients With Actinic Keratosis: Qualitative AnalysisRohan Singh, Sarah McCain, Steven R Feldman
The Annals of Pharmacotherapy|June 21, 2023
Choosing Systemic Agents for PsoriasisChristina Kontzias, Rithi Chandy, Steven R Feldman
The Journal of Dermatological Treatment|August 14, 2019
A new spin on improving adherenceVignesh Ramachandran, Arjun M Bashyam, Steven R Feldman
The Journal of Dermatological Treatment|July 7, 2009
Conversations on psoriasis--what patients want and what physicians can provide: a qualitative look at patient and physician expectationsElizabeth E Uhlenhake, David Kurkowski, Steven R Feldman
Dermatology Online Journal|March 9, 2011
Commentary: psoriasis patients with a history of malignancy represent an important but overlooked study populationPaul Persad, Michelle M Levender, Steven R Feldman
Pageof 130

Showing results (201-210 of 1,291) with videos related to

Sort By:
Pageof 130
Journal of the American Academy of Dermatology|February 18, 2010
Where did current academic dermatologists train?Ali Alikhan, Dina Farshidi, Steven R Feldman
Dermatology and Therapy|July 15, 2018
Effect of Prior Biologic Use on Cost-Effectiveness of Brodalumab vs. Ustekinumab for Treatment of Moderate-to-Severe Psoriasis in the United StatesSteven R Feldman, Shipra Rastogi, Jay Lin
Southern Medical Journal|May 13, 2009
Management of psoriasisAida J Al-Kudwah, Steven R Feldman
Journal of Drugs in Dermatology : JDD|June 16, 2006
Clobetasol propionate for psoriasis: are ointments really more potent?Lindsey Warino, Rajesh Balkrishnan, Steven R Feldman
Southern Medical Journal|January 5, 2017
Advances in PsoriasisJaclyn Smith, Abigail Cline, Steven R Feldman
JMIR Dermatology|August 26, 2023
Refusal of Retreatment With Topical 5-Fluorouracil Among Patients With Actinic Keratosis: Qualitative AnalysisRohan Singh, Sarah McCain, Steven R Feldman
The Annals of Pharmacotherapy|June 21, 2023
Choosing Systemic Agents for PsoriasisChristina Kontzias, Rithi Chandy, Steven R Feldman
The Journal of Dermatological Treatment|August 14, 2019
A new spin on improving adherenceVignesh Ramachandran, Arjun M Bashyam, Steven R Feldman
The Journal of Dermatological Treatment|July 7, 2009
Conversations on psoriasis--what patients want and what physicians can provide: a qualitative look at patient and physician expectationsElizabeth E Uhlenhake, David Kurkowski, Steven R Feldman
Dermatology Online Journal|March 9, 2011
Commentary: psoriasis patients with a history of malignancy represent an important but overlooked study populationPaul Persad, Michelle M Levender, Steven R Feldman
Pageof 130